Next Generation Sequencing of Cerebrospinal Fluid B Cell Repertoires in Multiple Sclerosis and Other Neuro-Inflammatory Diseases-A Comprehensive Review.
B cell repertoire
B cells
CSF
MS
NGS
NMOSD
limbic encephalitis
multiple sclerosis
next-generation sequencing
Journal
Diagnostics (Basel, Switzerland)
ISSN: 2075-4418
Titre abrégé: Diagnostics (Basel)
Pays: Switzerland
ID NLM: 101658402
Informations de publication
Date de publication:
11 Oct 2021
11 Oct 2021
Historique:
received:
05
07
2021
revised:
29
09
2021
accepted:
05
10
2021
entrez:
23
10
2021
pubmed:
24
10
2021
medline:
24
10
2021
Statut:
epublish
Résumé
During the last few decades, the role of B cells has been well established and redefined in neuro-inflammatory diseases, including multiple sclerosis and autoantibody-associated diseases. In particular, B cell maturation and trafficking across the blood-brain barrier (BBB) has recently been deciphered with the development of next-generation sequencing (NGS) approaches, which allow the assessment of representative cerebrospinal fluid (CSF) and peripheral blood B cell repertoires. In this review, we perform literature research focusing on NGS studies that allow further insights into B cell pathophysiology during neuro-inflammation. Besides the analysis of CSF B cells, the paralleled assessment of peripheral blood B cell repertoire provides deep insights into not only the CSF compartment, but also in B cell trafficking patterns across the BBB. In multiple sclerosis, CSF-specific B cell maturation, in combination with a bidirectional exchange of B cells across the BBB, is consistently detectable. These data suggest that B cells most likely encounter antigen(s) within the CSF and migrate across the BBB, with further maturation also taking place in the periphery. Autoantibody-mediated diseases, such as neuromyelitis optica spectrum disorder and LGI1 / NMDAR encephalitis, also show features of a CSF-specific B cell maturation and clonal connectivity with peripheral blood. In conclusion, these data suggest an intense exchange of B cells across the BBB, possibly feeding autoimmune circuits. Further developments in sequencing technologies will help to dissect the exact pathophysiologic mechanisms of B cells during neuro-inflammation.
Identifiants
pubmed: 34679570
pii: diagnostics11101871
doi: 10.3390/diagnostics11101871
pmc: PMC8534365
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : Medizinischen Fakultät, Eberhard Karls Universität Tübingen
ID : fortüne/PATE no 2536-0-0
Organisme : Medizinischen Fakultät, Eberhard Karls Universität Tübingen
ID : fortüne/PATE no 2536-0-1
Organisme : Medizinischen Fakultät, Eberhard Karls Universität Tübingen
ID : fortüne no 2536-0-0
Organisme : Bundesministerium für Bildung und Forschung
ID : No 01ZX1301F
Organisme : Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg
ID : BioDATEN
Références
Ann Neurol. 2004 Jul;56(1):97-107
pubmed: 15236406
Seizure. 2013 Mar;22(2):136-40
pubmed: 23318046
J Immunol. 2017 Nov 1;199(9):3369-3380
pubmed: 28978691
Bioinformatics. 2015 Oct 15;31(20):3356-8
pubmed: 26069265
Front Immunol. 2020 Jul 29;11:1539
pubmed: 32849520
Cell Rep Med. 2021 May 18;2(5):100288
pubmed: 33969321
J Neuroimmunol. 2007 Feb;183(1-2):189-99
pubmed: 17169437
Arch Neurol. 2008 Nov;65(11):1443-8
pubmed: 18779415
Nat Rev Immunol. 2021 May 11;:
pubmed: 33976421
JCI Insight. 2019 Mar 21;4(6):
pubmed: 30747723
BMC Biotechnol. 2017 Jul 10;17(1):61
pubmed: 28693542
Immunology. 2012 Mar;135(3):183-91
pubmed: 22043864
J Immunol. 1999 Nov 1;163(9):5133-44
pubmed: 10528220
J Clin Invest. 1998 Sep 1;102(5):1045-50
pubmed: 9727074
Ann Neurol. 2008 Mar;63(3):395-400
pubmed: 18383069
Nucleic Acids Res. 2015 Jan;43(Database issue):D413-22
pubmed: 25378316
Neurotherapeutics. 2021 Jan;18(1):364-377
pubmed: 33258072
Brain. 2005 Jul;128(Pt 7):1667-76
pubmed: 15800022
Nature. 2019 Oct;574(7776):122-126
pubmed: 31554970
Nucleic Acids Res. 2012 Sep 1;40(17):e134
pubmed: 22641856
Leukemia. 2016 Dec;30(12):2283-2292
pubmed: 27499139
Microbiol Spectr. 2014 Oct;2(5):
pubmed: 26104353
Ann Neurol. 2009 Nov;66(5):617-29
pubmed: 19938104
Proc Natl Acad Sci U S A. 2020 Sep 15;117(37):22932-22943
pubmed: 32859762
Brain. 2016 Oct;139(Pt 10):2641-2652
pubmed: 27543972
J Clin Invest. 2019 Apr 8;129(5):2000-2013
pubmed: 30958797
J Neuroimmunol. 2009 Aug 18;213(1-2):123-30
pubmed: 19631394
Nat Med. 2008 Jun;14(6):688-93
pubmed: 18488038
Lancet Neurol. 2018 Feb;17(2):162-173
pubmed: 29275977
PLoS One. 2013 Dec 10;8(12):e83036
pubmed: 24340077
Nat Immunol. 2017 Feb;18(2):123-131
pubmed: 28092374
Nat Rev Dis Primers. 2020 Oct 22;6(1):85
pubmed: 33093467
Neurology. 2015 Jul 14;85(2):177-89
pubmed: 26092914
Neurol Neuroimmunol Neuroinflamm. 2020 Feb 6;7(2):
pubmed: 32029531
Nat Commun. 2019 Jul 16;10(1):3120
pubmed: 31311926
J Immunol. 2003 Sep 1;171(5):2725-33
pubmed: 12928426
Ann Neurol. 2014 Feb;75(2):266-76
pubmed: 24375699
N Engl J Med. 2008 Feb 14;358(7):676-88
pubmed: 18272891
Clin Immunol. 2001 Feb;98(2):258-63
pubmed: 11161983
Bioinformatics. 2020 Mar 1;36(6):1731-1739
pubmed: 31873728
Nat Commun. 2020 Jan 14;11(1):247
pubmed: 31937773
Bioinformatics. 2015 Sep 15;31(18):2963-71
pubmed: 25987567
Curr Opin Neurol. 2018 Dec;31(6):752-759
pubmed: 30300239
JAMA Neurol. 2013 Sep 1;70(9):1110-7
pubmed: 23897062
Front Immunol. 2013 Dec 23;4:456
pubmed: 24391640
Bioinformatics. 2014 Jul 1;30(13):1930-2
pubmed: 24618469
Neurology. 2000 Mar 28;54(6):1227-32
pubmed: 10746589
Neurology. 2007 May 22;68(21):1815-9
pubmed: 17515543
Ann Clin Transl Neurol. 2017 May 09;4(6):369-380
pubmed: 28589164
Brain. 2014 Oct;137(Pt 10):2703-14
pubmed: 25060097
MAbs. 2015;7(3):516-24
pubmed: 25875140
Lancet Neurol. 2007 Sep;6(9):805-15
pubmed: 17706564
Brain. 2011 Feb;134(Pt 2):534-41
pubmed: 21216828
J Neuroinflammation. 2017 Feb 21;14(1):40
pubmed: 28222766
Neurol Neuroimmunol Neuroinflamm. 2015 May 07;2(3):e104
pubmed: 25977932
J Neuroimmunol. 2005 Jan;158(1-2):170-81
pubmed: 15589051
Neurology. 2014 Feb 18;82(7):573-81
pubmed: 24453078
Nat Commun. 2013;4:2333
pubmed: 23995877
Lancet. 2004 Dec 11-17;364(9451):2106-12
pubmed: 15589308
J Neuroimmunol. 2019 Aug 15;333:576966
pubmed: 31153015
J Immunol Methods. 2008 Sep 30;338(1-2):67-74
pubmed: 18706908
Sci Transl Med. 2014 Aug 6;6(248):248ra106
pubmed: 25100740
Ann Neurol. 1998 Feb;43(2):236-43
pubmed: 9485065
Proc Natl Acad Sci U S A. 2009 Dec 1;106(48):20216-21
pubmed: 19875695
Neurology. 2006 May 23;66(10):1485-9
pubmed: 16717206
Front Immunol. 2019 Apr 30;10:899
pubmed: 31114573
J Neuroinflammation. 2019 Nov 14;16(1):219
pubmed: 31727097
Nat Biotechnol. 2021 Feb;39(2):236-245
pubmed: 32895550
J Neurol. 2014 Jan;261(1):130-43
pubmed: 24162037
Front Immunol. 2018 Jul 26;9:1687
pubmed: 30093903
JCI Insight. 2017 Nov 16;2(22):
pubmed: 29202449
Nucleic Acids Res. 2013 Jul;41(Web Server issue):W34-40
pubmed: 23671333
Lancet. 2011 Nov 19;378(9805):1779-87
pubmed: 22047971
J Neuroimmunol. 2010 Jan 25;218(1-2):134-9
pubmed: 19900722
Sci Transl Med. 2014 Aug 6;6(248):248ra107
pubmed: 25100741
J Exp Med. 2005 Aug 15;202(4):473-7
pubmed: 16087714
Cell Mol Immunol. 2021 Feb;18(2):294-306
pubmed: 32728203
J Neuroinflammation. 2015 Jan 28;12:19
pubmed: 25626447
Ann Neurol. 2020 Mar;87(3):405-418
pubmed: 31900946
J Clin Invest. 2012 Dec;122(12):4533-43
pubmed: 23160197
N Engl J Med. 2017 Jan 19;376(3):209-220
pubmed: 28002688
J Immunol. 2000 Mar 1;164(5):2782-9
pubmed: 10679121
J Neuroimmunol. 2008 Aug 13;199(1-2):126-32
pubmed: 18547652
J Neuroimmunol. 2011 Apr;233(1-2):245-8
pubmed: 21353315
JAMA Neurol. 2019 Jul 1;76(7):841-849
pubmed: 31034002
Nat Rev Neurol. 2020 Sep;16(9):481-492
pubmed: 32724223
N Engl J Med. 2017 Jan 19;376(3):221-234
pubmed: 28002679
J Neuroimmunol. 2005 Oct;167(1-2):120-30
pubmed: 16099056
Nat Rev Neurosci. 2019 Dec;20(12):728-745
pubmed: 31712781
Clin Immunol. 2015 Oct;160(2):211-25
pubmed: 26055752
Lancet Neurol. 2014 Feb;13(2):167-77
pubmed: 24360484
Proc Natl Acad Sci U S A. 2016 Jul 12;113(28):7864-9
pubmed: 27325759